Prognostic significance of DNA ploidy and proliferation rate in human astrocytic gliomas

Folia Histochemica et Cytobiologica

Volumn 38, Issue 4, 2000, Pages 175-180

  Gasinska, A ^a   Krzyszkowski, T ^a   Niemiec, J ^a   Adamczyk, A ^a   Skolyszewski, J ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

AgNOR; Bromodeoxyuridine labelling index; DNA ploidy; Gliomas; Proliferation rate; SPF

Indexed keywords

BROXURIDINE; DNA;

ADULT; ANEUPLOIDY; ARGYROPHILIA; ARTICLE; ASTROCYTOMA; ASTROCYTOSIS; BIOPSY; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL KINETICS; CELL PROLIFERATION; CHROMOSOME NOR; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROSURGERY; PLOIDY; PROGNOSIS; SURVIVAL RATE;

EID: 0033782735     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Split course multiple daily fractionated radiotherapy schedule combined with misonidazole for the management of grade III and IV gliomas
2. Cell-kinetic characteristics of human brain tumors
3. Bromodeoxyuridine labeling index in glioblastoma multiforme: Relation to radiation response, age, and survival
4. Boron neutron capture therapy for glioblastoma multiforme: Interim results from the phase I/II dose-escalation studies
5. Hyperbaric oxygen and radiation therapy in the management of glioblastoma
6. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine
7. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas
8. Regression models and life-tables
9. Prognostic value of DNA ploidy and proliferative activity in human malignant gliomas
10. The radioresponse of human tumors and the initial slope of the cell survival curve
11. Nucleolar organizer regions (AgNORs) in primary and recurrent gliomas
12. Argyrophilic nucleolar organizer region (AgNOR) counting in astrocytic gliomas: Prognostic value
13. Correlation between bromodeoxyuridine labeling indices and patient prognosis in cerebral astrocytic tumors of adults
14. Flow cytometric DNA analysis and BrdUrd labelling index in brain tumours
15. Flow cytometric analysis of DNA ploidy and proliferative potential in brain tumours
16. DNA ploidy, bromodeoxyuridine labelling index, S-phase fraction and AgNOR counts in brain tumours
17. Three-dimensional co-location of RNA polymerase I and DNA during interphase and mitosis by confocal microscopy
18. Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant gliomas A preliminary report on a randomised trial
19. Altered therapy schedules in postoperative treatment of patients with malignant gliomas
20. Randomised comparisons of BCNU, streptozotocin, radiosensitizer and fractionation of radiotherapy in the post-operative treatment of malignant glioma (study 7702)
21. AgNOR - Analysis of astrocytoma in childhood
22. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas
23. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling
24. Non-parametric estimation for incomplete observations
25. Czy parametry kinetyki komorkowej i ploidalnosci DNA maja znaczenie prognostyczne u chorych na nowotwory mozgu
26. Randomised neutron dose searching study for malignant gliomas of the brain: Results of an RTOG study
27. Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: Relations with grade of malignancy and proliferation indices
28. Flow-cytometric analysis and immunohistochemical measurement of Ki-67 and BUdR labelling indices in human brain tumors
29. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme
30. Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomised prospective clinical trial
31. Proliferative potential of human brain tumours as assessed by nucleolar organizer regions (AgNORs) and Ki-67 immunoreactivity
32. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level
33. Proliferating cell nuclear antigen (PCNA): Expression in samples of human astrocytic gliomas
34. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry
35. Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme
36. Meningiomas: Clinical implications of a high proliferative potential determined by bromodeoxyuridine labelling
37. Proliferative potential of brain tumors
38. In vitro studies of cell proliferation in tumours. I. Critical appraisal of methods and theoretical consideration
39. Experimental techniques for cell kinetic studies
40. Prognostic relevance of cell proliferation markers and DNA-ploidy in gliomas
41. In vitro intrinsic radiation sensitivity of glioblastoma multiforme
42. Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas